Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Molecular Dx, Alpha Innotech to Integrate Tools for CGH Research

NEW YORK (GenomeWeb News) - Alpha Innotech and CombiMatrix Molecular Diagnostics will integrate certain of their technologies to create a tool for comparative genomic hybridization, the companies said yesterday.
 
The deal is centered on Alpha's AlphaScan laser scanner and CMDX's CGH arrays for neonatal screening and biomarker discovery, and calls for CMDX to integrate the AlphaScan scanner into its CGH platform.
 
CMDX CEO Matt Watson said his firm's customers "are looking for a single integrated platform that will enable them to quickly set up a CGH laboratory and begin running experiments." He said the AlphaScan "represents a key component of that platform."
 
Financial terms were not disclosed.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.